Clinical trial
Molecular Mechanisms Underlying the Protective Effects of Whole Red Raspberries Against Insulin Resistance and Inflammation in Type 2 Diabetes
NCT04306406 is registered in ClinicalTrials.gov with Pennington Biomedical Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Mechanisms Underlying the Protective Effects of Whole Red Raspberries Against Insulin Resistance and Inflammation in Type 2 Diabetes
- Lead sponsor
- Pennington Biomedical Research Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 7, 2015
- Completion date
- January 13, 2017
- Enrollment
- 9 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.